Clinical Trial Update: COGNIShunt® System for Alzheimer's Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial of the COGNIShunt System for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Eunoe | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED